Aspen Neuroscience, Inc.(ASPE)内部人交易:高管与董事近期交易
过去 18 个月,共有 18 位内部人为 Aspen Neuroscience, Inc.(ASPE)报告了 136 笔 Form 4 交易(最近一笔 2026-11-09)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-09 | Hasnain Faheem | Executive Chair | 买入 | 321,672 | $0 |
| 2026-11-04 | OrbiMed Capital GP VII LLC | 董事 | 买入 | 625,743 | $0 |
| 2026-11-04 | Thompson Peter A. | 董事 | 买入 | 196,541 | $0 |
| 2026-11-04 | OrbiMed Capital GP VII LLC | 董事 | 买入 | 196,541 | $0 |
| 2026-11-04 | ORBIMED ADVISORS LLC | 董事 | 买入 | 642,745 | $0 |
| 2026-11-04 | Thompson Peter A. | 董事 | 买入 | 642,745 | $0 |
| 2026-11-04 | OrbiMed Capital GP VII LLC | 董事 | 买入 | 642,745 | $0 |
| 2026-11-04 | ORBIMED ADVISORS LLC | 董事 | 买入 | 616,984 | $0 |
| 2026-11-04 | Thompson Peter A. | 董事 | 买入 | 616,984 | $0 |
| 2026-11-04 | OrbiMed Capital GP VII LLC | 董事 | 买入 | 616,984 | $0 |
| 2026-11-04 | ORBIMED ADVISORS LLC | 董事 | 买入 | 625,743 | $0 |
| 2026-11-04 | Thompson Peter A. | 董事 | 买入 | 625,743 | $0 |
| 2026-11-04 | ORBIMED ADVISORS LLC | 董事 | 买入 | 196,541 | $0 |
| 2026-11-04 | ORBIMED ADVISORS LLC | 董事 | 买入 | 507,119 | $0 |
| 2026-11-04 | Thompson Peter A. | 董事 | 买入 | 507,119 | $0 |
| 2026-11-04 | OrbiMed Capital GP VII LLC | 董事 | 买入 | 507,119 | $0 |
| 2026-11-04 | ORBIMED ADVISORS LLC | 董事 | 买入 | 1.0M | $15.0M |
| 2026-11-04 | Thompson Peter A. | 董事 | 买入 | 1.0M | $15.0M |
| 2026-11-04 | OrbiMed Capital GP VII LLC | 董事 | 买入 | 1.0M | $15.0M |
| 2026-11-02 | BERNS PAUL L | 10% 以上股东 | 买入 | 1.2M | $18.0M |
| 2026-11-02 | CRANDELL KEITH | 10% 以上股东 | 买入 | 66,666 | $999,990 |
| 2026-11-02 | NELSEN ROBERT | 10% 以上股东 | 买入 | 66,666 | $999,990 |
| 2026-11-02 | GILLIS STEVEN | 10% 以上股东 | 买入 | 66,666 | $999,990 |
| 2026-11-02 | Hasnain Faheem | Executive Chair | 买入 | 14,913 | $0 |
| 2026-11-02 | Burow Kristina | 10% 以上股东 | 买入 | 66,666 | $999,990 |
来源:SEC Form 4 申报文件 · 截至 2026-11-09